Pembrolizumab, Lenalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Eligible for Stem Cell Transplant
Clinical trial NCT02880228 · COMPLETED
Trial details
- NCT number
- NCT02880228
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-16
- Primary completion
- 2017-07-06
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.